Day: February 26, 2026

Physician Interview Now Available Key HighlightsResponder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company’s peer-reviewed randomized controlled trial. CMS Payment Rate: $300 national Medicare payment rate established, effective January 1, 2026. Physician Perspective: New interview with Gastroenterologist Dr. Dak Patel about inFoods IBS in clinical use now available at https://investors.biomerica.com/events-and-presentations/default.aspxIRVINE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), an innovator in diagnostic-guided therapy, today announced responder analysis results from its ongoing real-world study of inFoods® IBS. The data demonstrates that a majority of...

LITTLE ROCK, Ark., Feb. 26, 2026 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leader in artificial intelligence-driven advertising technology, will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, March 5, 2026. The Company will host a conference call at 4:15 p.m. Eastern Time that same day to discuss the results and provide a business update. Conference Call Details: Date: Thursday, March 5, 2026Time: 4:15 p.m. Eastern Time Toll-free Dial-in Number: 1-800-717-1738International Dial-in Number: 1-646-307-1865Conference ID: 1145199Webcast Link: HERE A telephone replay will be available through Thursday, March 19, 2026. To access the replay, please dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international). At the system prompt, please enter...

Raanana, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced results from a comparative study evaluating the regional nasal deposition profile of its naloxone formulation versus a commercial reference product. The study was conducted at the University of Parma’s Biopharmanet-TEC research center under the scientific supervision of Prof. Fabio Sonvico. The laboratory specializes in the research and development of intranasally administered technologies. The evaluation was performed using a validated silicone nasal cast model (Koken® LM-005) combined with quantitative image analysis. Results demonstrated that Polyrizon’s formulation achieved significantly higher deposition in...

~ Management to Participate in the 38th Annual ROTH Conference ~ GARDEN CITY, N.Y., Feb. 26, 2026 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT) (“Lifetime” or the “Company”), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, will release its fourth quarter and full year 2025 financial results before market open on Thursday, March 12, 2026. The Company will host a conference call to discuss the results on the same day at 11:00 a.m. Eastern Time. Investors and analysts may access the live conference call by dialing 1-844-826-3035 (USA) or 1-412-317-5195 (International). In addition, a live webcast of the conference call will be accessible through the investor relations website here. For those who cannot listen to the live broadcast, an audio replay of the...

HARRISBURG, Pa., Feb. 26, 2026 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today announced that it will report its financial results for the fourth quarter and fiscal year 2025 before the market opens on Thursday, March 12, 2026. Eric van der Valk, President and Chief Executive Officer, and Robert Helm, Executive Vice President and Chief Financial Officer, will host a conference call with the investment community to discuss the financial results and answer questions at 8:30 a.m. Eastern Time on the same day. To access the live conference call, please pre-register here. Registrants will receive a confirmation with dial-in instructions. Interested parties can also listen to a live webcast or replay of the conference call by logging on to the Investor Relations section on the Company’s website...

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” or the “Company”), today announced management will participate in a fireside chat and hold one-on-one meetings at the 2026 Leerink Global Healthcare Conference taking place March 8-11 in Miami, Florida. Fireside Date: Tuesday, March 10Time: 3:00pm ESTWebcast: Linked here and archived for 90 days on events page on the Imagene IR website About ImageneBio, Inc. Imagene is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. The Company’s program, IMG-007, is a receptor targeting, nondepleting anti-OX40 monoclonal antibody with multiple differentiating features. Imagene has completed Phase 1b/2a clinical trials of IMG-007...

EDGEWOOD, N.Y., Feb. 26, 2026 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero” or the “Company”) (NYSE American: CVU) announced that Embraer S.A. of Brazil (NYSE: EMBJ) has placed several additional orders totaling $4.2 million against a previously announced Life of Program Agreement to manufacture engine inlet assemblies for the Embraer Phenom 300 business jets. These new orders will see deliveries continue through mid-2026 with continued funding anticipated in support of this life-of-program contract. Embraer Executive Aviation’s Phenom 300 continues to lead its class, with 72 units delivered in 2025, the highest in 15 years, reinforcing production upside into 2026. “CPI Aero has been a supplier of Engine Inlets to Embraer since 2012. As of December 2025, we have delivered over 940 shipsets for the Phenom 300 business...

Successfully integrated and validated systems across a complex, multi-partner ground architecture SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, has successfully completed the Critical Design Review (CDR) for the Space Development Agency’s Advanced Fire Control Ground Infrastructure (AFCGI) system. Kratos’ completion of the CDR with zero liens allows the program to continue an accelerated schedule and remain aligned with anticipated launch dates. Kratos completed the AFCGI CDR only eight months after the program’s Preliminary Design Review, which itself was finished in just five months from contract award, underscoring the company’s ability to advance complex systems on a rapid timeline. In 2024 Kratos...

CHINO, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) — Karat Packaging Inc. (“Karat” or the “Company”) (Nasdaq: KRT), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced it will release its 2025 fourth quarter and full year financial results after market close on Thursday, March 12, 2026. The Company will host an investor conference call on the same day.Call Date: Thursday, March 12, 2026Time: 2:00 p.m. PT/5:00 p.m. ETPhone: 877-418-4045 (domestic); 412-317-6745 (international)Conference ID: Karat Packaging Inc.Webcast: Accessible at https://irkarat.com/events-presentations/; archive available for approximately one yearAbout Karat Packaging Inc. Karat Packaging Inc. is a specialty distributor and manufacturer of a wide range of disposable...

SHENZHEN, China, Feb. 26, 2026 (GLOBE NEWSWIRE) — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, proposed a quantum AI simulator that adopts a hybrid CPU-FPGA method. This system performs hardware-level optimization on the specific structure of quantum kernels through a heterogeneous computing architecture, making quantum kernel estimation 500 times faster than traditional CPU simulation implementations under the same computational scale, providing unprecedented acceleration capabilities for the application simulation of quantum artificial intelligence. This technology of HOLO focuses on application-specific quantum kernels (ASQK) designed for image classification tasks, and for the first time implements its core computational process on a Field Programmable Gate Array...